Concepedia

Molecular Markers in Key Steroidogenic Pathways, Circulating Steroid Levels, and Prostate Cancer Progression

Éric Lévesque, Shu‐Pin Huang, Étienne Audet‐Walsh, Louis Lacombe, Bo‐Ying Bao, Yves Fradet, Isabelle Laverdière, Mélanie Rouleau, Chao‐Yuan Huang, Chia‐Cheng Yu,

Clinical Cancer Research · 2012 · 56 citations · 28 references

DOI

Abstract

This study identifies, in different ethnic groups and at different disease stages, CYP17A1, HSD17B2, and ESR1 as attractive prognostic molecular markers of prostate cancer progression.

References

28

Global cancer statistics

Ahmedin Jemal, Freddie Bray · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Statistical significance for genomewide studies

John D. Storey, Robert Tibshirani · Proceedings of the National Academy of Sciences · 2003 · 9.9K citations · Full text

, , +21

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.3K citations · Full text

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

Bruce Montgomery, Elahe A. Mostaghel, Robert L. Vessella et al. · Cancer Research · 2008 · 1.4K citations · Full text

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

Howard I. Scher, Tomasz M. Beer, Celestia S. Higano et al. · The Lancet · 2010 · 1.1K citations · Full text

, , +8